[8-K] Tempest Therapeutics, Inc. Reports Material Event
Tempest Therapeutics reported that it has issued a press release announcing its financial results for the quarter ended June 30, 2025. The press release is attached to this report as Exhibit 99.1. This Form 8-K indicates the company is furnishing the press release rather than "filing" it, meaning the release is provided for investor information in this report but is not subject to the liabilities of being formally filed or automatically incorporated by reference in other Securities Act filings. The 8-K itself does not include the numerical financial statements; those figures are contained in the attached press release.
Tempest Therapeutics ha comunicato di aver diffuso un comunicato stampa con i risultati finanziari per il trimestre terminato il 30 giugno 2025. Il comunicato stampa 猫 allegato a questo rapporto come Exhibit 99.1. Il presente Modulo 8-K indica che la societ脿 sta "fornendo" il comunicato piuttosto che "depositarlo" (filing), il che significa che il comunicato 猫 incluso in questo rapporto a scopo informativo per gli investitori ma non 猫 soggetto alle responsabilit脿 derivanti da un deposito formale n茅 猫 automaticamente incorporato per riferimento in altre dichiarazioni ai sensi del Securities Act. L'8-K in s茅 non contiene i prospetti finanziari numerici; tali cifre sono riportate nel comunicato stampa allegato.
Tempest Therapeutics inform贸 que ha emitido un comunicado de prensa con los resultados financieros del trimestre concluido el 30 de junio de 2025. El comunicado est谩 adjunto a este informe como Exhibit 99.1. Este Formulario 8-K indica que la compa帽铆a est谩 "proporcionando" el comunicado en lugar de "presentarlo" (filing), lo que significa que el comunicado se incluye en este informe para informaci贸n de los inversores pero no est谩 sujeto a las responsabilidades de un dep贸sito formal ni se incorpora autom谩ticamente por referencia en otros documentos bajo el Securities Act. El propio 8-K no incluye los estados financieros num茅ricos; esas cifras aparecen en el comunicado adjunto.
Tempest Therapeutics電� 2025雲� 6鞗� 30鞚�鞐� 膦呺霅� 攵勱赴鞚� 鞛 鞁れ爜鞚� 氚滍憸頃橂姅 氤措弰鞛愲毳� 氚滍憸頄堧嫟瓿� 氤搓碃頄堨姷雼堧嫟. 頃措嫻 氤措弰鞛愲電� 氤� 氤搓碃靹滌潣 Exhibit 99.1搿� 觳秬霅橃柎 鞛堨姷雼堧嫟. 氤� Form 8-K電� 須岇偓臧� 頃措嫻 氤措弰鞛愲毳� '鞝滌稖(filing)'頃橂姅 雽�鞁� '鞝滉车(furnishing)'頃橁碃 鞛堨潓鞚� 氇呾嫓頃╇媹雼�. 鞚措姅 氤措弰鞛愲臧� 氤� 氤搓碃靹滌棎靹� 韴瀽鞛� 彀戈碃鞖╈溂搿� 鞝滉车霅橃毵� 瓿奠嫕 鞝滌稖鞐� 霐半ジ 氩曥爜 毂呾瀯鞚� 雽�靸侅澊 鞎勲媹氅� Securities Act靸侅潣 雼るジ 鞝滌稖靹滊鞐� 鞛愲彊鞙茧 韽暔霅橃 鞎婌潓鞚� 鞚橂頃╇媹雼�. 8-K 鞛愳泊鞐愲姅 靾橃箻頇旊悳 鞛鞝滍憸臧� 韽暔霅橃柎 鞛堨 鞎婌溂氅�, 頃措嫻 靾橃箻電� 觳秬霅� 氤措弰鞛愲鞐� 旮办灛霅橃柎 鞛堨姷雼堧嫟.
Tempest Therapeutics a annonc茅 qu'elle avait publi茅 un communiqu茅 de presse pr茅sentant ses r茅sultats financiers pour le trimestre clos le 30 juin 2025. Le communiqu茅 est joint 脿 ce rapport en tant que Exhibit 99.1. Ce formulaire 8-K indique que la soci茅t茅 met le communiqu茅 脿 la disposition du public ("furnishing") plut么t que de le "d茅poser" ("filing"), ce qui signifie que le communiqu茅 est fourni dans ce rapport 脿 titre d'information pour les investisseurs mais n'est pas soumis aux responsabilit茅s d'un d茅p么t formel ni automatiquement int茅gr茅 par renvoi dans d'autres documents au titre du Securities Act. Le 8-K lui-m锚me n'inclut pas les 茅tats financiers chiffr茅s ; ces chiffres figurent dans le communiqu茅 ci-joint.
Tempest Therapeutics teilte mit, dass es eine Pressemitteilung mit den Finanzergebnissen f眉r das zum 30. Juni 2025 endende Quartal herausgegeben hat. Die Pressemitteilung ist diesem Bericht als Exhibit 99.1 beigef眉gt. Dieses Formular 8-K weist darauf hin, dass das Unternehmen die Pressemitteilung "zur Verf眉gung stellt" (furnishing) und sie nicht "einreicht" (filing). Das bedeutet, dass die Mitteilung in diesem Bericht zu Informationszwecken f眉r Investoren enthalten ist, jedoch nicht den Haftungsregelungen einer f枚rmlichen Einreichung unterliegt und nicht automatisch durch Verweis in andere Unterlagen nach dem Securities Act aufgenommen wird. Das 8-K selbst enth盲lt keine numerischen Finanzabschl眉sse; diese Zahlen sind in der beigef眉gten Pressemitteilung enthalten.
- None.
- None.
Insights
TL;DR: The company furnished a press release with Q2 2025 results; the 8-K contains no financial figures, so impact cannot be assessed from this filing alone.
The filing communicates that Tempest released its quarterly results for the period ended June 30, 2025 and attached the release as Exhibit 99.1. Because the 8-K only furnishes the press release and does not include the underlying financial statements or metrics, there is insufficient information here to judge revenue, profitability, cash position, or trend changes. Investors must review Exhibit 99.1 for quantitative results and disclosures.
TL;DR: The company explicitly furnished the press release rather than filing it, limiting Section 18 liability and incorporation by reference.
The 8-K states the press release is being "furnished" and therefore is not deemed "filed" under the Exchange Act, which is a common procedural distinction that limits certain statutory liabilities and prevents automatic incorporation into future Securities Act filings. The filing also identifies the press release as Exhibit 99.1, but does not present the underlying financial tables within the body of the 8-K. From a governance perspective, this is a routine disclosure mechanism; material assessment requires the attached exhibit.
Tempest Therapeutics ha comunicato di aver diffuso un comunicato stampa con i risultati finanziari per il trimestre terminato il 30 giugno 2025. Il comunicato stampa 猫 allegato a questo rapporto come Exhibit 99.1. Il presente Modulo 8-K indica che la societ脿 sta "fornendo" il comunicato piuttosto che "depositarlo" (filing), il che significa che il comunicato 猫 incluso in questo rapporto a scopo informativo per gli investitori ma non 猫 soggetto alle responsabilit脿 derivanti da un deposito formale n茅 猫 automaticamente incorporato per riferimento in altre dichiarazioni ai sensi del Securities Act. L'8-K in s茅 non contiene i prospetti finanziari numerici; tali cifre sono riportate nel comunicato stampa allegato.
Tempest Therapeutics inform贸 que ha emitido un comunicado de prensa con los resultados financieros del trimestre concluido el 30 de junio de 2025. El comunicado est谩 adjunto a este informe como Exhibit 99.1. Este Formulario 8-K indica que la compa帽铆a est谩 "proporcionando" el comunicado en lugar de "presentarlo" (filing), lo que significa que el comunicado se incluye en este informe para informaci贸n de los inversores pero no est谩 sujeto a las responsabilidades de un dep贸sito formal ni se incorpora autom谩ticamente por referencia en otros documentos bajo el Securities Act. El propio 8-K no incluye los estados financieros num茅ricos; esas cifras aparecen en el comunicado adjunto.
Tempest Therapeutics電� 2025雲� 6鞗� 30鞚�鞐� 膦呺霅� 攵勱赴鞚� 鞛 鞁れ爜鞚� 氚滍憸頃橂姅 氤措弰鞛愲毳� 氚滍憸頄堧嫟瓿� 氤搓碃頄堨姷雼堧嫟. 頃措嫻 氤措弰鞛愲電� 氤� 氤搓碃靹滌潣 Exhibit 99.1搿� 觳秬霅橃柎 鞛堨姷雼堧嫟. 氤� Form 8-K電� 須岇偓臧� 頃措嫻 氤措弰鞛愲毳� '鞝滌稖(filing)'頃橂姅 雽�鞁� '鞝滉车(furnishing)'頃橁碃 鞛堨潓鞚� 氇呾嫓頃╇媹雼�. 鞚措姅 氤措弰鞛愲臧� 氤� 氤搓碃靹滌棎靹� 韴瀽鞛� 彀戈碃鞖╈溂搿� 鞝滉车霅橃毵� 瓿奠嫕 鞝滌稖鞐� 霐半ジ 氩曥爜 毂呾瀯鞚� 雽�靸侅澊 鞎勲媹氅� Securities Act靸侅潣 雼るジ 鞝滌稖靹滊鞐� 鞛愲彊鞙茧 韽暔霅橃 鞎婌潓鞚� 鞚橂頃╇媹雼�. 8-K 鞛愳泊鞐愲姅 靾橃箻頇旊悳 鞛鞝滍憸臧� 韽暔霅橃柎 鞛堨 鞎婌溂氅�, 頃措嫻 靾橃箻電� 觳秬霅� 氤措弰鞛愲鞐� 旮办灛霅橃柎 鞛堨姷雼堧嫟.
Tempest Therapeutics a annonc茅 qu'elle avait publi茅 un communiqu茅 de presse pr茅sentant ses r茅sultats financiers pour le trimestre clos le 30 juin 2025. Le communiqu茅 est joint 脿 ce rapport en tant que Exhibit 99.1. Ce formulaire 8-K indique que la soci茅t茅 met le communiqu茅 脿 la disposition du public ("furnishing") plut么t que de le "d茅poser" ("filing"), ce qui signifie que le communiqu茅 est fourni dans ce rapport 脿 titre d'information pour les investisseurs mais n'est pas soumis aux responsabilit茅s d'un d茅p么t formel ni automatiquement int茅gr茅 par renvoi dans d'autres documents au titre du Securities Act. Le 8-K lui-m锚me n'inclut pas les 茅tats financiers chiffr茅s ; ces chiffres figurent dans le communiqu茅 ci-joint.
Tempest Therapeutics teilte mit, dass es eine Pressemitteilung mit den Finanzergebnissen f眉r das zum 30. Juni 2025 endende Quartal herausgegeben hat. Die Pressemitteilung ist diesem Bericht als Exhibit 99.1 beigef眉gt. Dieses Formular 8-K weist darauf hin, dass das Unternehmen die Pressemitteilung "zur Verf眉gung stellt" (furnishing) und sie nicht "einreicht" (filing). Das bedeutet, dass die Mitteilung in diesem Bericht zu Informationszwecken f眉r Investoren enthalten ist, jedoch nicht den Haftungsregelungen einer f枚rmlichen Einreichung unterliegt und nicht automatisch durch Verweis in andere Unterlagen nach dem Securities Act aufgenommen wird. Das 8-K selbst enth盲lt keine numerischen Finanzabschl眉sse; diese Zahlen sind in der beigef眉gten Pressemitteilung enthalten.
FAQ
What did Tempest Therapeutics (TPST) disclose in this 8-K?
Does this 8-K include the company's financial statements or numeric results?
Is the press release in this 8-K considered "filed" with the SEC?
Where can I find the full press release with the financial results?
Who signed the 8-K for Tempest Therapeutics?
